Latest News & Features
Americas
Merck has added two US patents to its CRISPR-Cas9 patent portfolio, and is already seeking licensing and product development partners, the German company announced yesterday, May 11. 12 May 2020
Americas
A trademark infringement complaint filed by 3M is “short on ultimate facts and long on inflammatory, derogatory, and conclusory assertions”, according to the company accused of price-gouging in the suit. 12 May 2020
Medtech
A California spacecraft laboratory has made its respirator designs available for free and signed up to the IP sharing scheme, Open COVID Pledge. 11 May 2020
Americas
The US Court of Appeals for the Federal Circuit has affirmed a generic maker’s victory over pharmaceutical company Eagle Pharmaceuticals in a case involving cancer drug Belrapzo. 11 May 2020
Big Pharma
IP firm HGF has appointed two patent attorneys to partner, increasing the partner group to 63 partners. 11 May 2020
Americas
The US Patent and Trademark Office will allow plant patent applications to be filed online due to the COVID-19 pandemic, it has announced. 7 May 2020
Americas
Canada-based Bausch Health has agreed to settle its dispute with generic maker Sandoz over the latter’s attempt to release a generic version of antibiotic Xifaxan. 7 May 2020
Americas
Criminal investigators in the US Homeland Security Investigations’ National Intellectual Property Rights Coordination Center have partnered with Pfizer, 3M, Citi, Alibaba, Amazon and Merck & Co to combat fraud and other illegal activity related to COVID-19. 6 May 2020
Americas
US customs authorities have seized tens of thousands of counterfeit and unapproved COVID-19 test kits, largely sent through the postal system, since the beginning of the pandemic. 5 May 2020
Asia-Pacific
An Australian federal judge has thrown out a challenge by Gilead Sciences to the wording of infringement claims made by a GlaxoSmithKline subsidiary. 5 May 2020